发明申请
US20080255112A1 Pyrimidine-Substituted Benzimidazole Derivatives as Protein Kinase Inhibitors 失效
嘧啶取代的苯并咪唑衍生物作为蛋白激酶抑制剂

Pyrimidine-Substituted Benzimidazole Derivatives as Protein Kinase Inhibitors
摘要:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of Alk, Abl, BRK, Blk, BMX, CSK, c-Src, c-Raf, EGFR, Fes, FGFR3, Fms, Fyn, IGF-IR, IR, IKKα, IKKβ, JAK2, JAK3, KDR, Lck, Met, p70S6k, Ros, Rsk1, SAPK2α, SAPK2β, SAPK3, SIK, Tie2, TrkB and/or WNK3 kinases.
信息查询
0/0